aiqbench analysis
TimeTeller's saliva-based assay targets chronotherapy by mapping individual circadian rhythms to optimize cancer treatment timing and mitigate side effects. While the technology bridges biology and data, its current utility lies in clinical research contexts rather than standalone consumer diagnostics for disease management. The core innovation remains the application of systems medicine principles to personalize oncology protocols based on endogenous biological clocks.
TimeTeller puts our internal clocks at the center of personalized medicine
German startup TimeTeller has developed a saliva test kit to help anyone understand their circadian rhythm; it aims to reduce side effects from cancer treatments.
At-home health testing has been mired in overblown claims and outright fraud. But German startup TimeTeller, which has developed a saliva test kit to help anyone understand their circadian rhythm, is led by CEO Angela Relógio, who is the polar opposite of Theranos’ disgraced founder Elizabeth Holmes. Relógio is a physicist-engineer and molecular biologist who spent years researching oncology, circadian biology, and systems medicine in Germany before leaving academia to build TimeTeller. She is careful about…
Excerpt shown under the publisher's RSS terms · 76 words · full text and figures are on the publisher's site
